Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,090 public trials 1,847 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Completed

Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer

NCT00063388

Conditions
Brain Damage, Chronic, Brain Diseases, Bronchial Neoplasms, +13 more
Locations
  • ImClone Investigational Site Aventura, Florida, United States
  • ImClone Investigational Site Miami Beach, Florida, United States
  • ImClone Investigational Site Chicago, Illinois, United States
  • ImClone Investigational Site Indianapolis, Indiana, United States
View Trial Details
Completed

Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

NCT00097227

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Santa Monica, California, United States
  • ImClone Investigational Site Newark, Delaware, United States
  • ImClone Investigational Site Orlando, Florida, United States
View all 20 locations
View Trial Details
Completed

Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

NCT00097214

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ImClone Investigational Site Bentonville, Arkansas, United States
  • ImClone Investigational Site Tucker, Georgia, United States
  • ImClone Investigational Site Evanston, Illinois, United States
  • ImClone Investigational Site Louisville, Kentucky, United States
View Trial Details
Completed

An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer

NCT00054899

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Cancer Centers of Florida Orlando, Florida, United States
  • New York Oncology Hematology Albany, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients

NCT00569114

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • City of Hope Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of California at Davis Sacramento, California, United States
View Trial Details

Related conditions